Novartis
BEOVU
Manufacturer:
Novartis
Name:
BEOVU
HCPCS Code Descriptor:
Injection, brolucizumab-dbll, 1 mg
Category:
J Code
HCPCS:
J0179
NDC(s):
00078-0827-60
Primary Type:
Opthalmic
Generic/Specialty Status:
Single-Source
Route of Administration:
Intraocular
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
BEOVU is an Opthalmic drug manufactured by Novartis and administered via the Intraocular route of administration. The J Code: J0179 is aligned to the drug BEOVU.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/20
HCPCS Effective Date:
1/1/20
HCPCS Short Description:
Inj, brolucizumab-dbll, 1 mg
Billing and Coding Guide:
https://p.widencdn.net/cgoqsr/BVU-1391588-BEOVU-J-Code-Billing--Coding-Guide---Electronic_PI-Update-6.20
Patient Assistance:
https://www.mygooddays.org/
https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment